These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23277097)

  • 1. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
    Jimenez HR; Hallit RR; Debari VA; Slim J
    Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to hepatitis A vaccination in HIV-infected men in Greece.
    Kourkounti S; Mavrianou N; Paparizos VA; Kyriakis K; Hatzivassiliou M; Kordosis T; Katsambas A
    Int J STD AIDS; 2012 Jul; 23(7):464-7. PubMed ID: 22843998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with seroconversion after standard dose hepatitis B vaccination and high-dose revaccination among HIV-infected patients.
    Pettit NN; DePestel DD; Malani PN; Riddell J
    HIV Clin Trials; 2010; 11(6):332-9. PubMed ID: 21239361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.
    Tedaldi EM; Baker RK; Moorman AC; Wood KC; Fuhrer J; McCabe RE; Holmberg SD;
    Clin Infect Dis; 2004 May; 38(10):1478-84. PubMed ID: 15156488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to hepatitis A virus vaccination in HIV-infected men who have sex with men.
    Kourkounti S; Paparizos V; Leuow K; Paparizou E; Antoniou C
    Int J STD AIDS; 2015 Oct; 26(12):852-6. PubMed ID: 25411352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A vaccination and immunological parameters in HIV-infected patients.
    Kourkounti S; Papaizos V; Leuow K; Kordosis T; Antoniou C
    Viral Immunol; 2013 Oct; 26(5):357-63. PubMed ID: 24044625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to hepatitis A vaccine in patients with HIV.
    Fritzsche C; Bergmann L; Loebermann M; Glass A; Reisinger EC
    Vaccine; 2019 Apr; 37(16):2278-2283. PubMed ID: 30890384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation.
    Jabłonowska E; Kuydowicz J
    Int J STD AIDS; 2014 Sep; 25(10):745-50. PubMed ID: 24452731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
    Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
    Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of vaccination against hepatitis A in HIV infected adults from Lodz region--preliminary report].
    Jabłonowska E; Kuydowicz J; Małolepsza E
    Przegl Epidemiol; 2008; 62(3):605-12. PubMed ID: 19108525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against viral hepatitis of HIV-1 infected patients.
    Phung BC; Launay O
    Hum Vaccin Immunother; 2012 May; 8(5):554-9. PubMed ID: 22634451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.